Skip to main content

Table 3 Utilisation of selected atypical antipsychotics in Austria as a percentage of total atypical antipsychotic use between 2005 and 2010 (defined daily dose basis)

From: Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications

Atypical antipsychotic

2005

2006

2007

2008

2009

2010

% Change

Risperidone

31.6

29.9

28.6

26.9

25.5

23.8

-25

Amisulpride

8.4

7.1

6.7

6.3

5.9

5.5

-35

Aripiprazole

2.5

5.4

7.2

9.1

10.6

11.8

376

Olanzapine

36.6

33.3

31.3

29.6

28.0

26.1

-29

Quetiapine

18.6

22.5

24.8

27.0

29.6

32.7

75

Paliperidone

0.00

0.00

0.00

0.02

0.04

0.03

NA

Zotepine

2.2

1.8

1.4

0.9

0.4

0.1

 
  1. NA, not applicable.